HUM
41
-4
VRSK
68
-12
HSIC
45
5
PYPL
52
-2
GILD
47
-8
NWSA
62
-7
STT
64
2
SIG
44
-3
IR
63
-3
BK
74
3
ILMN
32
-9
ROST
57
-3
AZO
50
-5
FIS
51
-4
SBUX
37
-2
ROP
53
-9
XEL
67
2
CVX
43
-3
JNJ
41
3
MRO
50
4
HUM
41
-4
VRSK
68
-12
HSIC
45
5
PYPL
52
-2
GILD
47
-8
NWSA
62
-7
STT
64
2
SIG
44
-3
IR
63
-3
BK
74
3
ILMN
32
-9
ROST
57
-3
AZO
50
-5
FIS
51
-4
SBUX
37
-2
ROP
53
-9
XEL
67
2
CVX
43
-3
JNJ
41
3
MRO
50
4
Financhill
Back

Aytu BioPharma Vs. Neurogene Industry Stock Comparison

Sell
37

AYTU
Aytu BioPharma

Last Price:
1.52
Seasonality Move:
12.49%
Sell
1

NGNE
Neurogene

Last Price:
34.67
Seasonality Move:
50.43%
Sell
37
Aytu BioPharma (AYTU) is a Sell

Is Aytu BioPharma a Buy, Sell or Hold?

  • The current Aytu BioPharma [AYTU] share price is $1.55. The Score for AYTU is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • AYTU is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
1
Neurogene (NGNE) is a Sell

Is Neurogene a Buy, Sell or Hold?

  • The current Neurogene [NGNE] share price is $34.52. The Score for NGNE is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
  • NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

AYTU Stock Price Chart

What is Aytu BioPharma's stock price today?

  • The Aytu BioPharma share price today is $1.55
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AYTU is experiencing selling pressure, which indicates risk of future bearish movement.

NGNE Stock Price Chart

What is Neurogene's stock price today?

  • The Neurogene share price today is $34.52
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NGNE is experiencing selling pressure, which indicates risk of future bearish movement.

AYTU Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.18 Sell
Relative Strength Index (14 RSI): 23.6 Sell
Chaikin Money Flow: -39198 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.75 - 2.21) Sell
Bollinger Bands (100): (2.1 - 2.76) Sell

NGNE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.55 Sell
Relative Strength Index (14 RSI): 35.74 Sell
Chaikin Money Flow: -452975 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.4 - 61.5) Sell
Bollinger Bands (100): (34.32 - 50.52) Sell

AYTU Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.71 Sell
20-day SMA: 1.91 Sell
50-day SMA: 2.21 Sell
200-day SMA: 2.71 Sell
8-day EMA: 1.7 Sell
20-day EMA: 1.88 Sell
50-day EMA: 2.13 Sell
200-day EMA: 2.61 Sell

NGNE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.3 Sell
20-day SMA: 51.47 Sell
50-day SMA: 46.76 Sell
200-day SMA: 38.99 Sell
8-day EMA: 47.13 Sell
20-day EMA: 50.2 Sell
50-day EMA: 47.47 Sell
200-day EMA: 38.44 Sell

Aytu BioPharma Earnings Growth & AYTU Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.44 per share, and a decrease next year of $0.00 per share.

Neurogene Earnings Growth & NGNE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.

Aytu BioPharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Neurogene Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):